Background: The test-negative design is an increasingly popular approach for estimating
vaccine effectiveness (VE) due to its efficiency. This review aims to examine published test …

Background: The test-negative design is a variant of the case–control study being
increasingly used to study influenza vaccine effectiveness (VE). In these studies, patients …

Vaccination remains the most effective way to prevent influenza infection, albeit vaccine
effectiveness (VE) varies by year. Compared to other age groups, children and elderly adults …

Vaccination represents the most effective intervention to prevent infection, hospitalization
and mortality due to influenza. This meta-analysis quantifies data reporting influenza …

Background The recombinant vesicular stomatitis virus–Zaire Ebola virus (rVSV-ZEBOV)
vaccine is the only WHO prequalified vaccine recommended for use to respond to outbreaks …

Abstract Background The World Health Organization recommends young children aged 6–
59 months receive influenza vaccination (IV) annually. This study investigated the IV …

Contrary to the long-held belief that the effects of vaccines are specific for the disease they
were created; compelling evidence has demonstrated that vaccines can exert positive or …

Objectives We assessed the vaccine effectiveness (VE) of inactivated influenza vaccine (IIV)
in children 6 months to 15 years of age in 2015/16 season. In addition, based on the data …

Purpose Seasonal influenza vaccination is recommended in children aged 6–59 months,
but little is known about child vaccination coverage and determinants in Asian settings. We …

School-based vaccination, as a means to mitigate seasonal influenza outbreak, depends on
attaining adequate coverage rate. We evaluated the potential of a fully subsidized school …